TY - JOUR
T1 - Occurrence and characterization of fungal species in medicinal plants from South Africa
AU - Oladeji, Oluwaseun Mary
AU - Phoku, Judith Zanele
AU - Adelusi, Oluwasola Abayomi
AU - Aasa, Oluwakemi Adeola
AU - Njobeh, Patrick Berka
N1 - Publisher Copyright:
© The Author(s) 2025.
PY - 2025/12
Y1 - 2025/12
N2 - Fungal contamination of medicinal plants poses significant health risks due to the potential production of mycotoxins. In South Africa (SA), medicinal plants are widely used in traditional healthcare, but their safety is often compromised by fungal colonization. This study investigated 36 different medicinal plants purchased from Faraday Muthi Market, Johannesburg, SA, for fungal level using both macro- and microscopic approaches, and their identities were confirmed by molecular means. The fungal loads of the mycoflora recovered from the medical plants ranged from 1.8 × 104 CFU/g to 2 × 107 CFU/g, exceeding the WHO regulatory limit of 1 × 103 CFU/g. Furthermore, a total of 164 fungal species from nine genera, including Aspergillus (39.6%), Penicillium (19.5%), and Fusarium (9.7%), other notable fungal genera such as Alternaria (5.5%), Mucor (5.4%), Rhizopus (5.4%), Chaetomium (4.2%), Cladosporium (3.6%), Emericella nidulans (3.6%) and Epicoccum (3.0%) were also recovered from the medicinal plants. Furthermore, A. niger (10.97%) was the most prevalent among all the identified fungal species. Consuming fungal-contaminated medicinal plants poses significant human health risks. The findings highlights the need for strict quality control during the cultivation, harvesting, and processing of medicinal plants in South Africa and across Africa to mitigate fungal contamination risks. Future research should focus on developing strategies to reduce fungal loads in medicinal plants.
AB - Fungal contamination of medicinal plants poses significant health risks due to the potential production of mycotoxins. In South Africa (SA), medicinal plants are widely used in traditional healthcare, but their safety is often compromised by fungal colonization. This study investigated 36 different medicinal plants purchased from Faraday Muthi Market, Johannesburg, SA, for fungal level using both macro- and microscopic approaches, and their identities were confirmed by molecular means. The fungal loads of the mycoflora recovered from the medical plants ranged from 1.8 × 104 CFU/g to 2 × 107 CFU/g, exceeding the WHO regulatory limit of 1 × 103 CFU/g. Furthermore, a total of 164 fungal species from nine genera, including Aspergillus (39.6%), Penicillium (19.5%), and Fusarium (9.7%), other notable fungal genera such as Alternaria (5.5%), Mucor (5.4%), Rhizopus (5.4%), Chaetomium (4.2%), Cladosporium (3.6%), Emericella nidulans (3.6%) and Epicoccum (3.0%) were also recovered from the medicinal plants. Furthermore, A. niger (10.97%) was the most prevalent among all the identified fungal species. Consuming fungal-contaminated medicinal plants poses significant human health risks. The findings highlights the need for strict quality control during the cultivation, harvesting, and processing of medicinal plants in South Africa and across Africa to mitigate fungal contamination risks. Future research should focus on developing strategies to reduce fungal loads in medicinal plants.
KW - Aspergillus
KW - Fungal contamination
KW - Fusarium
KW - Health risk
KW - Medicinal plants
KW - South Africa
UR - http://www.scopus.com/inward/record.url?scp=85218506293&partnerID=8YFLogxK
U2 - 10.1007/s11084-025-09682-9
DO - 10.1007/s11084-025-09682-9
M3 - Article
AN - SCOPUS:85218506293
SN - 0169-6149
VL - 55
JO - Discover Life
JF - Discover Life
IS - 1
M1 - 6
ER -